Skip to content
10-Q

Quarterly Report

CHINA BCT PHARMACY GROUP, INC.

0001213900-12-006242

← back to feed
Filed
Nov 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 9, 2012 38.15M sh
Capex Q3 2012 · Sep 30, 2012 $2.59M
Capex Q3 2012 · Sep 30, 2011 $1.89M
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$10.74M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$4.84M
Long Term Debt Q3 2012 · Sep 30, 2012 $229.1K
Long Term Debt Q3 2012 · Dec 31, 2011 $2.02M
Short Term Debt Q3 2012 · Sep 30, 2012 $11.02M
Short Term Debt Q3 2012 · Dec 31, 2011 $7.23M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $19.37M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $31.48M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $34.26M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $20.16M
Current Liabilities Q3 2012 · Sep 30, 2012 $67.26M
Current Liabilities Q3 2012 · Dec 31, 2011 $62.1M
Total Liabilities Q3 2012 · Sep 30, 2012 $67.57M
Total Liabilities Q3 2012 · Dec 31, 2011 $62.68M
Current Assets Q3 2012 · Sep 30, 2012 $194.24M
Current Assets Q3 2012 · Dec 31, 2011 $172.09M
Total Assets Q3 2012 · Sep 30, 2012 $236.59M
Total Assets Q3 2012 · Dec 31, 2011 $212.58M
Sga Expense Q3 2012 · Sep 30, 2012 $2.57M
Sga Expense Q3 2012 · Sep 30, 2012 $7.19M
Sga Expense Q3 2012 · Sep 30, 2011 $2.13M
Sga Expense Q3 2012 · Sep 30, 2011 $7.84M
Operating Income Q3 2012 · Sep 30, 2012 $5.82M
Operating Income Q3 2012 · Sep 30, 2012 $26.5M
Operating Income Q3 2012 · Sep 30, 2011 $12.45M
Operating Income Q3 2012 · Sep 30, 2011 $32.7M
Gross Profit Q3 2012 · Sep 30, 2012 $10.75M
Gross Profit Q3 2012 · Sep 30, 2012 $40.61M
Gross Profit Q3 2012 · Sep 30, 2011 $16.3M
Gross Profit Q3 2012 · Sep 30, 2011 $45.98M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $44.65M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $147.13M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $51.18M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $145.22M
Revenue Q3 2012 · Sep 30, 2012 $55.4M
Revenue Q3 2012 · Sep 30, 2012 $187.75M
Revenue Q3 2012 · Sep 30, 2011 $67.48M
Revenue Q3 2012 · Sep 30, 2011 $191.2M